Citation Impact
Citing Papers
Disseminated and sustained HIV infection in CD34 + cord blood cell-transplanted Rag2 −/− γ c −/− mice
2006
High-throughput characterization of protein–protein interactions by reprogramming yeast mating
2017 StandoutNobel
CD25+CD4+ Regulatory T Cells from the Peripheral Blood of Asymptomatic HIV-infected Individuals Regulate CD4+ and CD8+ HIV-specific T Cell Immune Responses In Vitro and Are Associated with Favorable Clinical Markers of Disease Status
2004
CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract
2004 Standout
High Coverage of ART Associated with Decline in Risk of HIV Acquisition in Rural KwaZulu-Natal, South Africa
2013 StandoutScience
CD4+ Count–Guided Interruption of Antiretroviral Treatment
2006 Standout
Cancer in Africa 2012
2014
Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1)
2013 StandoutNobel
Cancer statistics, 2022
2022 Standout
CD4+ Tregs and immune control
2004 StandoutNobel
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Youths and HIV/AIDS: Psychiatry's Role in a Changing Epidemic
2005
X4 and R5 HIV-1 Have Distinct Post-entry Requirements for Uracil DNA Glycosylase during Infection of Primary Cells
2010 StandoutNobel
Enhancing SIV-specific immunity in vivo by PD-1 blockade
2008 Nature
Combination of HIV‐1–Specific CD4 Th1 Cell Responses and IgG2 Antibodies Is the Best Predictor for Persistence of Long‐Term Nonprogression
2005
Barriers to HAART Adherence Among Human Immunodeficiency Virus–Infected Adolescents
2003
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Global trends in emerging infectious diseases
2008 StandoutNature
Identification of a CCR5-Expressing T Cell Subset That Is Resistant to R5-Tropic HIV Infection
2007
Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
1999 Standout
Regulatory T cells in virus infections
2006
Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know
2004
Transmission, acute HIV-1 infection and the quest for strategies to prevent infection
2003
In Vitro Derived Dendritic Cells trans-Infect CD4 T Cells Primarily with Surface-Bound HIV-1 Virions
2007
The inhibitory cytokine IL-35 contributes to regulatory T-cell function
2007 StandoutNature
HIV vaccines 1983–2003
2003
Strong and persistent CD4+ T-cell response in healthy adults immunized with a candidate HIV-1 vaccine containing gp120, Nef and Tat antigens formulated in three Adjuvant Systems
2010
‘Self-Protection’ of Individual CD4+ T Cells against R5 HIV-1 Infection by the Synthesis of Anti-Viral CCR5 Ligands
2008
Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
2015 Standout
Promise and problems associated with the use of recombinant AAV for the delivery of anti-HIV antibodies
2016
A Prospective, Randomized Trial of Structured Treatment Interruption for Patients with Chronic HIV Type 1 Infection
2005
Polyfunctional T cell responses are a hallmark of HIV‐2 infection
2008
Progress on new vaccine strategies against chronic viral infections
2004
The interaction of HIV with dendritic cells: outcomes and pathways
2007 StandoutNobel
HIV Drug Resistance
2004
The challenge of emerging and re-emerging infectious diseases
2004 StandoutNature
Restoring function in exhausted CD8 T cells during chronic viral infection
2005 StandoutNatureNobel
Dendritic Cells In Vivo: A Key Target for a New Vaccine Science
2008 StandoutNobel
The blockade of immune checkpoints in cancer immunotherapy
2012 Standout
Mental health of young people: a global public-health challenge
2007 Standout
Immunopathogenesis and immunotherapy in AIDS virus infections
2003
Perils at mucosal front lines for HIV and SIV and their hosts
2005
FOXP3+ regulatory T cells in the human immune system
2010 StandoutNobel
Seventeen-colour flow cytometry: unravelling the immune system
2004
CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial
2006
Advances in understanding immunologic control of HIV infection
2004
Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection
2005 StandoutNature
Infection in Solid-Organ Transplant Recipients
2007 Standout
Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS
2005 StandoutNobel
Microfluidic diagnostic technologies for global public health
2006 StandoutNature
Nonpathogenic SIV Infection of Sooty Mangabeys Is Characterized by Limited Bystander Immunopathology Despite Chronic High-Level Viremia
2003
Phenotype and function of myeloid dendritic cells derived from African green monkey blood monocytes
2005 StandoutNobel
Adherence to Medication
2005 Standout
Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates
2011 StandoutNobel
Increases in Adult Life Expectancy in Rural South Africa: Valuing the Scale-Up of HIV Treatment
2013 Science
Interleukin‐2 Up‐Regulates Expression of the Human Immunodeficiency Virus Fusion Coreceptor CCR5 by CD4+Lymphocytes In Vivo
2000 StandoutNobel
Intensified and protective CD4+ T cell immunity in mice with anti–dendritic cell HIV gag fusion antibody vaccine
2006 StandoutNobel
DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8 + T cells in a spectrum of human MHC I haplotypes
2007 StandoutNobel
Myeloid and plasmacytoid dendritic cells transfer HIV-1 preferentially to antigen-specific CD4+ T cells
2005
APOBEC3G/3F mediates intrinsic resistance of monocyte-derived dendritic cells to HIV-1 infection
2006 StandoutNobel
Clonal B cells in patients with hepatitis C virus–associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset
2011 StandoutNobel
Differential Susceptibility to Human Immunodeficiency Virus Type 1 Infection of Myeloid and Plasmacytoid Dendritic Cells
2005
Decreased Survival of B Cells of HIV-viremic Patients Mediated by Altered Expression of Receptors of the TNF Superfamily
2004
CD4+ Tregs and immune control
2004 StandoutNobel
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Priming of protective T cell responses against virus-induced tumors in mice with human immune system components
2009 StandoutNobel
Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum
2011 StandoutScience
In Vivo Targeting of Antigens to Maturing Dendritic Cells via the DEC-205 Receptor Improves T Cell Vaccination
2004 StandoutNobel
Presence of HIV-1 Gag-Specific IFN-γ+IL-2+ and CD28+IL-2+ CD4 T Cell Responses Is Associated with Nonprogression in HIV-1 Infection
2002
Dendritic cells cross-present HIV antigens from live as well as apoptotic infected CD4 + T lymphocytes
2004
Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells
2003
Mature Dendritic Cells Infected with Canarypox Virus Elicit Strong Anti-Human Immunodeficiency Virus CD8+and CD4+T-Cell Responses from Chronically Infected Individuals
2001 StandoutNobel
Macrophage Colony-Stimulating Factor Antagonists Inhibit Replication of HIV-1 in Human Macrophages
2000
Containment of Simian Immunodeficiency Virus Infection in Vaccinated Macaques: Correlation with the Magnitude of Virus-Specific Pre- and Postchallenge CD4+ and CD8+ T Cell Responses
2002
Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS
2005 StandoutNobel
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit
2008 StandoutNobel
Dendritic cells and HIV-specific CD4+ T cells: HIV antigen presentation, T-cell activation, and viral transfer
2006
Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses
2008 StandoutNobel
The Fluorescent Toolbox for Assessing Protein Location and Function
2006 StandoutScienceNobel
Distinctive NK-cell receptor repertoires sustain high-level constitutive NK-cell activation in HIV-exposed uninfected individuals
2007 StandoutNobel
The Engagement of Activating FcγRs Inhibits Primate Lentivirus Replication in Human Macrophages
2006 StandoutNobel
Dendritic cell targeted HIV gag protein vaccine provides help to a DNA vaccine including mobilization of protective CD8 + T cells
2010 StandoutNobel
The Trojan exosome hypothesis
2003
Latent reservoirs of HIV: Obstacles to the eradication of virus
1999
HIV VACCINES
2005
Reducing Poverty-Related Disparities in Cervical Cancer: The Role of HPV Vaccination
2021
Progress on new vaccine strategies against chronic viral infections
2004
HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation
2004 StandoutNobel
Transfer and Evaluation of an Automated, Low-Cost Real-Time Reverse Transcription-PCR Test for Diagnosis and Monitoring of Human Immunodeficiency Virus Type 1 Infection in a West African Resource-Limited Setting
2005
Natural killer cells in HIV-1 infection: Dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates
2003
CD4 T Cell Depletion Is Linked Directly to Immune Activation in the Pathogenesis of HIV-1 and HIV-2 but Only Indirectly to the Viral Load
2002
The microbial mimic poly IC induces durable and protective CD4+T cell immunity together with a dendritic cell targeted vaccine
2008 StandoutNobel
Human immunodeficiency virus–driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients
2004
Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load
2004
Works of Mark Dybul being referenced
Long‐Cycle Structured Intermittent versus Continuous Highly Active Antiretroviral Therapy for the Treatment of Chronic Infection with Human Immunodeficiency Virus: Effects on Drug Toxicity and on Immunologic and Virologic Parameters
2003
HIV preferentially infects HIV-specific CD4+ T cells
2002 Nature
Structured treatment interruption: Approaches and risks
2002
Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy
1999
Guidelines for Using Antiretroviral Agents among HIV-Infected Adults and Adolescents: The Panel on Clinical Practices for Treatment of HIV*
2002
Life Expectancy of Persons Receiving Combination Antiretroviral Therapy in Low-Income Countries: A Cohort Analysis From Uganda
2011
Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: Effects on virologic, immunologic, and toxicity parameters
2001
Ending cervical cancer: A call to action
2017
Guidelines for Using Antiretroviral Agents Among HIV-Infected Adults and Adolescents: Recommendations of the Panel on Clinical Practices for Treatment of HIV
2002